Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride and dutasteride effectively treat hair loss, with dutasteride showing slightly better results.

5α-reductase inhibitors, like finasteride and dutasteride, effectively treat BPH, male baldness, and hirsutism, with potential for acne and prostate cancer prevention.

Taking 5-ARI before prostate laser surgery may lead to more blood changes, longer surgery, and more urinary issues.

Tailored treatments for alopecia areata show promising results, with pulse steroids effective for mild cases and Ritlecitinib, Dupilumab, or methotrexate and prednisone effective for severe cases.

Baricitinib can cause excessive hair growth.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with less inflammation.

DHA-NLC may improve drug delivery and reduce side effects for cancer treatment.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

Dutasteride effectively treats enlarged prostate with manageable side effects.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

In 2002, various drugs caused serious side effects, including vitamin B12 deficiency, heart issues, blindness, hypersexuality, allergic reactions, blood clotting problems, pupil dilation, capillary leak syndrome, muscle breakdown, hepatitis, skin reactions, and lupus.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Finasteride is high-risk for cognitive disorders, while Carbidopa/Levodopa, Topiramate, and Clonazepam are moderate-risk.

Adenosine receptors could be promising targets for treating inflammatory skin diseases like psoriasis.

Finasteride may be linked to more psychiatric issues than dutasteride, but a definite cause isn't proven.

Adapalene, Diosmin, and Azelastine may effectively treat onchocerciasis.

Adapalene, Diosmin, and Azelastine may effectively treat onchocerciasis.

Azathioprine is the most continued treatment for chronic alopecia areata over a year, often with added low-dose prednisolone.

The new particle system could be a promising treatment for diseases related to the 5-α reductase enzyme.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Aminopterin effectively improves skin conditions but has toxic side effects that need careful monitoring.

DHT enhances androgen receptor activity more than testosterone, and MAGE-11 influences this activity through specific interactions.

Three natural compounds from Ghanaian plants may help treat BPH and alopecia.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Different types of androgens bind differently to two receptors, AR1 and AR2, in Atlantic croaker's brain and ovarian tissues, suggesting these receptors may control different androgen actions in fish.

Anti-androgens might help reduce COVID-19 severity in men.

Interest in JAK inhibitors for alopecia areata increased significantly after FDA approval, highlighting the need for patient education.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.